Early expression of interferon-γ/inducible protein 10 and monokine induced by interferon-γ in cardiac allografts is mediated by CD8+ T cells

Transplantation

Volumn 69, Issue 6, 2000, Pages 1147-1155

  Kapoor, Anil ^a   Morita, Ken ^a   Engeman, Tara M ^a   Koga, Shoji ^a   Vapnek, Evan M ^a   Hobart, Michael G ^a   Fairchild, Robert L ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOATTRACTANT; CHEMOKINE; GAMMA INTERFERON;

ALLOGRAFT; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; COMPLEMENT ACTIVATION; EFFECTOR CELL; GRAFT SURVIVAL; HEART TRANSPLANTATION; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RECIPIENT; T LYMPHOCYTE ACTIVATION;

EID: 0034719868     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003270-00020     Document Type: Article

References (40)

1. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994; 331: 365.
2. Paul LC, Fellstrom B. Chronic vascular rejection of the heart and the kidney-have rational treatment options emerged? Transplantation 1992; 53: 1169.
3. Paul L. Chronic renal transplant loss. Kidney Int 1995; 47: 1491.
4. Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994; 57: 857.
5. Hall B. Cells mediating allograft rejection. Transplantation 1991; 51: 51.
6. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1993; 10: 333.
7. Pizzaro TT, Malinowska K, Kovacs EJ, Clancy J, Robinson JA, Piccini LA. Induction of TNFα and TNFβ gene expression in rat cardiac transplants during allograft rejection. Transplantation 1993; 56: 399.
8. Clausell N, Molossi S, Rabinovitch M. Increased interleukin-1β and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets. Am J Pathol 1993; 142: 1772.
9. Mannon RB, Sundar SK, Sanfillipo FP, Coffman TM. Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone. Transplantation 1993; 56: 1157.
10. DeMeester SR, Rolfe MW, Kunkel SL, et al. The bimodal expression of tumor necrosis factor-α in association with rat lung reimplantation and allograft rejection. J Immunol 1993; 150: 2494.
11. Taub DD, Oppenheim JJ. Chemokines, inflammation, and immunity. Ther Immunol 1994; 1: 229.
12. Rollins BJ. Chemokines. Blood 1997; 90: 909.
13. Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA. Role of macrophage inflammatory protein-1α (MIP-1α) in acute lung injury in rats. J Immunol 1995; 154: 4793.
14. Smith RE, Strieter RM, Phan SH, et al. Production and function of murine macrophage inflammatory protein-1α in bleomycin-induced lung injury. J Immunol 1994; 153: 4704.
15. Gong J-H, Ratkay LG, Waterfield JD, Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 1997; 186: 131.
16. Lloyd CM, Minto AW, Dorf ME, et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997; 185: 1371.
17. Russell ME, Adams DH, Wyner LR, Yamashita Y, Halnon NJ, Karnovsky MJ. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc Natl Acad Sci USA 1993; 90: 6086.
18. Wieder KJ, Hancock WW, Schmidbauer G, et al. Rapamycin treatment depresses intragraft expression of KC/MIP-2, Granzyme B, and IFN-γ in rat recipients of cardiac allografts. J Immunol 1993; 151: 1158.
19. Schmouder RL, Strieter RM, Walz A, Kunkel SL. Epithelial-derived neutrophil-activating factor-78 production in human renal tubule epithelial cells and in renal allograft rejection. Transplantation 1995; 59: 118.
20. Pattison J, Nelson PJ, Huie P, et al. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994; 1 209.
21. Pattison JM, Nelson PJ, Huie P, Sibley RK, Krensky AM. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant 1996; 15: 1194.
22. Nadeau KC, Azuma H, Tilney NL. Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA 1995; 92: 8729.
23. Nagano H, Nadeau KC, Takada M, Kusaka M, Tilney NL. Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats. Transplantation 1997; 63: 1101.
24. Luster AD, Ravetch JV. Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J Exp Med 1987; 166: 1084.
25. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM. Human Mig chemokine: biochemical and functional characterization. J Exp Med 1995; 182: 1301.
26. Fairchild RL, VanBuskirk AM, Kondo T, Wakely ME, Orosz CG. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Transplantation 1997; 63: 1807.
27. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 16: 343.
28. Orosz CG, Wakely E, Bergese SD, et al. Prevention of murine cardiac allograft rejection with gallium nitrate. Transplantation 1996; 61: 783.
29. Kondo T, Novick AC, Toma H, Fairchild RL. Induction of chemokine gene expression during allogeneic skin graft rejection. Transplantation 1996; 61: 1750.
30. Hoglund P, Sundback J, Olsson-Alheim MY, et al. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol Rev 1997; 155: 11.
31. Bishop DK, Shelby J, Eichwald EJ. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Transplantation 1992; 53: 849.
32. Konieczny BT, Dai Z, Elwood ET, et al. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160: 2059.
33. Kondo T, Morita K, Watarai Y, et al. Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation 2000; 69: 969.
34. Cuturi MC, Anegon I, Sherman F, et al. Production of hematopoietic colony-stimulating factors by human natural killer cells. J Exp Med 1989; 169: 569.
35. Strieter RM, Kunkel SL, Showell HJ, et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNFα, LPS/and IL-1β. Science 1989; 243: 1467.
36. Mantovani A, Bussolino G, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992; 6: 2591.
37. Robson SC, Candinas D, Hancock WW, Wrighton C, Winkler H, Bach FH. Role of endothelial cells in transplantation. Int Arch Allergy Immunol 1995; 106: 305.
38. Briscoe DM, Henault LE, Geehan C, Alexander SI, Lichtman AH. Human endothelial cell costimulation of T cell IFN-γ production. J Immunol 1997; 159: 3247.
39. + cells are essential for allorejection. J Exp Med 1996; 184: 2013.
40. Koga S, Auerbach MB, Engeman TM, Novick AC, Toma H, Fairchild RL. T cell infiltration into class II MHC disparate allografts and acute rejection is dependent on the IFN-γ induced chemokine Mig. J Immunol 1999; 163: 4878.